XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
NCT ID: NCT00731237
Last Updated: 2009-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2517 participants
OBSERVATIONAL
2008-10-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
NCT01120379
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
NCT00531011
XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
NCT00631228
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease
NCT01310309
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period
NCT00882219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
The procedures undergone by this group will be evaluated for: Acute performance, deliverability and resource utilization during the procedure in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Alternatively, the patient's legally authorized representative agrees to the patient's participation in this study and signs the informed consent form prior to the index procedure.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abbott Vascular
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John McPherson, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbuilt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Heart Center, PC
Huntsville, Alabama, United States
Arizona Regional Medical Center
Mesa, Arizona, United States
Tri Lakes Research-Central Arkansas Cardiovascular
Hot Springs, Arkansas, United States
Tri Lakes Research-Central Arkansas Cardiovascular
Hot Springs Village, Arkansas, United States
NEA Baptist Memorial Hospital
Jonesboro, Arkansas, United States
La Mesa Cardiac Center
La Mesa, California, United States
Pikes Peak Cardiology
Colorado Springs, Colorado, United States
University of Connecticut Health Center
Farmington, Connecticut, United States
Bradenton Heart Research Center
Bradenton, Florida, United States
Ocala Regional Medical Center
Ocala, Florida, United States
Harbin Clinic LLC
Rome, Georgia, United States
Sherman Hospital
Elgin, Illinois, United States
Heart Care Research Foundation
Mokena, Illinois, United States
Northern Indiana Research Alliance
Fort Wayne, Indiana, United States
Clarian Health Partners - Methodist Hospital
Indianapolis, Indiana, United States
Medical Consultants PC
Muncie, Indiana, United States
Iowa Heart Center
Des Moines, Iowa, United States
University of Iowa Hospital
Iowa City, Iowa, United States
Promise Regional Medical Center - Hutchinson
Hutchinson, Kansas, United States
Allegiance Health
Jackson, Michigan, United States
Michigan Cardiovascular Institute
Midland, Michigan, United States
Michigan Cardio Vascular Institute at St. Mary's of MI
Saginaw, Michigan, United States
Coast Cardiovascular Consultants, P.L.L.C
Biloxi, Mississippi, United States
St. Luke's
Kansas City, Missouri, United States
St. Johns Mercy Medical Center
St Louis, Missouri, United States
Renown Regional Medical Center
Reno, Nevada, United States
AtlantiCare Regional Medical Center
Pomona, New Jersey, United States
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
First Health Moore Regional Hospital
Pinehurst, North Carolina, United States
Fairfield Cardiac Cath Lab, LLC
Fairfield, Ohio, United States
Smith Clinic
Marion, Ohio, United States
St. Anthony Hospital
Oklahoma City, Oklahoma, United States
Conemaugh Valley Memorial Hospital
Johnstown, Pennsylvania, United States
The Good Samaritan Hospital
Lebanon, Pennsylvania, United States
Phoenixville Hospital
Phoenixville, Pennsylvania, United States
University Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania, United States
UPMC Presbyterian Shadyside Hospital
Pittsburgh, Pennsylvania, United States
Palmetto Health Clinic
Columbia, South Carolina, United States
Piedmont Medical Center / Carolina Cardiology Associates
Rock Hill, South Carolina, United States
Wellmont Bristol Regional Medical Center
Bristol, Tennessee, United States
Tomball Regional Medical Center
Tomball, Texas, United States
Virginia Cardiovascular Specialists
Richmond, Virginia, United States
Cardiovascular Associates, Ltd.
Virginia Beach, Virginia, United States
CAMC Health Education and Research Institute, Inc.
Charleston, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-382
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.